Process information
| Key Data Set Information | |
| Location | SD-CN |
| Reference year | 2022 |
| Name |
|
| Use advice for data set | When integrating this data set into Life Cycle Assessment models, users should ensure that the data corresponds to a similar technological standard and that the scope of environmental impacts includes all stages described, from seed culture through to the drying of finished products. Consideration should be given to the inclusion of potential upstream impacts from the production of raw materials and downstream impacts from the use of the pharmaceutical product. |
| Technical purpose of product or process | The Acarbose produced via this process is intended for pharmaceutical applications. It serves as an active pharmaceutical ingredient (API) in medications used for the management of type 2 diabetes. |
| Classification |
Class name
:
Hierarchy level
|
| General comment on data set | The information comes from the environmental assessment report of the enterprise and represents the actual production situation of the enterprise |
| Copyright | No |
| Owner of data set | |
| Quantitative reference | |
| Reference flow(s) | |
| Time representativeness | |
| Time representativeness description | Environmental impact assessment report publication date |
| Technological representativeness | |
| Technology description including background system | Acarbose was produced by biological fermentation, including seed culture, fermentation, refining and drying of finished products |
| Flow diagram(s) or picture(s) | |
Modelling and validation
Administrative information
Inputs and Outputs